排序方式: 共有12条查询结果,搜索用时 0 毫秒
11.
Oligoclonal T cells in human cancer 总被引:5,自引:0,他引:5
Eva Halapi 《Cancer immunology, immunotherapy : CII》1998,15(4):203-211
Many solid tumors are characterised by the infiltration of lymphocytes and their presence has been correlated with a more
favourable prognosis. These tumor-infiltrating lymphocytes (TIL), have been shown to possess specific cytolytic reactivity
towards autologous tumours, thus suggesting that tumour cells may express antigens capable of eliciting an immune response.
Expression of such tumour-associated antigens (TAA) in combination with appropriate accessory signals would lead to thein vivo accumulation of T cells with anti-tumour specificity. Analysis of the composition of the specific T-cell receptor (TCR) of
TIL could thus provide information on the nature of the antigen(s) recognised by TIL. In this review, different aspects of
the presence of clonal T cells in patients with cancer are discussed. 相似文献
12.
《MABS-AUSTIN》2013,5(4):662-671
The potential for immunogenicity is an ever-present concern during the development of biopharmaceuticals. Therapeutic antibodies occasionally elicit an antibody response in patients, which can result in loss of response or adverse effects. However, antibodies that bind a drug are sometimes found in pre-treatment serum samples, with the amount depending on drug, assay, and patient population. This review summarizes published data on pre-existing antibodies to therapeutic antibodies, including rheumatoid factors, anti-allotype antibodies, anti-hinge antibodies, and anti-glycan antibodies. Unlike anti-idiotype antibodies elicited by the drug, pre-formed antibodies in general appear to have little consequences during treatment. In the few cases where (potential) clinical consequences were encountered, antibodies were characterized and found to bind a distinct, unusual epitope of the therapeutic. Immunogenicity testing strategies should therefore always include a proper level of antibody characterization, especially when pre-formed antibodies are present. This minimizes false-positives, particularly due to rheumatoid factors, and helps to judge the potential threat in case a genuine pre-dose antibody reactivity is identified. 相似文献